Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21.0Revenue (TTM) $M5.5Net Margin (%)-354.6Altman Z-Score-21.6
Enterprise Value $M0.6EPS (TTM) $-5.5Operating Margin %-427.4Piotroski F-Score2
P/E(ttm)--Beneish M-Score-5.7Pre-tax Margin (%)-354.4Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio2.3Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-88.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-320.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ONTX is held by these investors:



ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy14,348$84.7-97.53view
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy14,348$84.7-97.53view
Kumar RameshPresident and CEO 2014-02-10Sell3,354$150.7-98.61view
Kumar RameshPresident and CEO 2014-02-03Sell6,000$150.5-98.61view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy5,730$119.2-98.25view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy5,730$119.2-98.25view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy500$143.9-98.55view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy500$143.9-98.55view
Reddy E PremkumarDirector 2013-11-18Buy500$121-98.27view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy500$118.7-98.24view

Press Releases about ONTX :

Quarterly/Annual Reports about ONTX:

    News about ontx:

    Articles On GuruFocus.com
    Onconova Therapeutics Announces Closing of Public Offering of Common Stock Apr 26 2017 
    Onconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC Apr 26 2017 
    Onconova Therapeutics Announces Pricing of Public Offering of Common Stock Apr 21 2017 
    Onconova Therapeutics Announces Proposed Public Offering of Common Stock Apr 20 2017 
    Onconova Therapeutics Announces Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5 In Apr 04 2017 
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results Mar 27 2017 
    Onconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences Mar 21 2017 
    Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results Mar 16 2017 
    Onconova Therapeutics, Inc. to Present at Two Healthcare Conferences in March Mar 02 2017 
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    Onconova Therapeutics Announces Closing of Public Offering of Common Stock Apr 26 2017
    Onconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC Apr 26 2017
    Onconova Therapeutics stock drops 12% after pricing stock offering Apr 21 2017
    Onconova Therapeutics Announces Pricing of Public Offering of Common Stock Apr 21 2017
    Onconova Therapeutics Announces Proposed Public Offering of Common Stock Apr 20 2017
    Company News for April 05, 2017 Apr 05 2017
    Onconova Therapeutics and Pluristem Therapeutics Surge as Candidate Drugs Move Closer to Final... Apr 05 2017
    Onconova Reports Positive Data for 2 Cancer Drugs Apr 04 2017
    Onconova Therapeutics stock surges 18% on positive pre-clinical data for cancer drugs Apr 04 2017
    Onconova Therapeutics Announces Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5... Apr 04 2017
    Onconova Therapeutics, Inc. :ONTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017 Mar 31 2017
    Edited Transcript of ONTX earnings conference call or presentation 27-Mar-17 1:00pm GMT Mar 28 2017
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results Mar 27 2017
    Onconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences Mar 21 2017
    Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results Mar 16 2017
    Onconova Therapeutics, Inc. to Present at Two Healthcare Conferences in March Mar 02 2017
    Onconova Therapeutics, Inc. to Present at Two Investor Conferences in February Feb 09 2017
    These 5 Stocks Under $10 Could Get Hot Soon Jan 27 2017
    SeeThruEquity Initiates Coverage on Onconova Therapeutics, Inc. (NASDAQ: ONTX) with a Price Target... Jan 12 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)